| 32.19 Data as of May 17 |  +0.21 / +0.66%Today’s Change | 23.73 Today|||52-Week Range 35.86 | +1.42% Year-to-Date |
| Previous close | 31.98 |
| Today’s open | 32.15 |
| Day’s range | 31.95 - 32.29 |
| Volume | 1,228,248 |
| Average volume (3 months) | 1,227,539 |
| Market cap | $3.6B |
| Dividend yield | 0.87% |
| Earnings growth (last year) | +5,859.00% |
| Earnings growth (this year) | -0.93% |
| Earnings growth (next 5 years) | +10.46% |
| Revenue growth (last year) | +10.09% |
| P/E ratio | 47.3 |
| Price/Sales | 1.67 |
| Price/Book | 1.91 |
| Today’s change | Today’s % change | |
|---|---|---|
| FEICFEI Co | +2.38 | +3.36% |
| BRKRBruker Corp | +0.08 | +0.48% |
| QGENQiagen NV | +0.05 | +0.27% |
| BIOBio-Rad Laboratories... | -1.11 | -0.95% |
| Next reporting date | July 25, 2013 |
| EPS forecast (this quarter) | $0.48 |
| Annual revenue (last year) | $2.1B |
| Annual profit (last year) | $68.4M |
| Net profit margin | 3.24% |
Sector Health Technology |
Industry Medical Specialties |
Chairman, President & Chief Executive Officer Robert F. Friel |
Chief Financial Officer & Senior Vice President Frank Anders Wilson, CPA |
Corporate headquarters Waltham, Massachusetts |
.
